Jerry Bagel

机构：VA New Jersey Health Care System, Windsor Dermatology, Icahn School of Medicine at Mount Sinai · ORCID：0000-0001-5241-0915

发表论文 244 篇 · 总被引 5985 次 · h-index 40

代表论文

• Roflumilast Foam, 0.3%, for Psoriasis of the Scalp and Body (2025 · JAMA Dermatology · 被引 17)
• Efficacy and safety of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis of the scalp: Week 52 results from a phase 3b, randomized, double-blind, placebo-controlled trial (2024 · Journal of the American Academy of Dermatology · 被引 9)
• Unmet Needs of Effective Advanced Systemic Therapies in Moderate-to-Severe Atopic Dermatitis Patients in the TARGET-DERM AD Registry (2025 · Dermatitis · 被引 7)
• Lebrikizumab Improves Clinical Manifestations, Symptoms, and Quality of Life in Patients with Moderate-to-Severe Atopic Dermatitis Previously Treated with Dupilumab: Results from the ADapt Study (2026 · Dermatology and Therapy · 被引 6)
• Efficacy and Safety of Risankizumab in Genital or Scalp Psoriasis in the UnlIMMited Phase 4 Randomized Clinical Trial at Week 16 (2025 · Dermatology and Therapy · 被引 6)
• Lebrikizumab Improves Atopic Dermatitis and Quality of Life in Patients With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab: Results From the ADapt Trial (2025 · SKIN The Journal of Cutaneous Medicine · 被引 6)